Posts Tagged ‘ blepharitis ’
InSite Vision Updates Special Protocol Assessment Submission To FDA For Phase 3 Trial Of AzaSite Plus™ And DexaSite™
InSite Vision Incorporated (OTCBB:INSV) today announced that the Company recently received eight minor recommendations regarding its proposed agreement with the U.S...
InSite Vision Awarded Therapeutic Discovery Project Grant for ISV-502 and ISV-303 Clinical Development
ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV), a company developing novel ophthalmic therapeutics, today announced that it will receive $489,000 under the U.S. Government's Qualifying Therapeutic Discovery Project ("QTDP") program.
Subscribe
